跳至主要内容
临床试验/NCT01861808
NCT01861808已完成不适用

Investigation on the Prognostic Value of Biochemical Markers in the Cerebrospinal Fluid for the Functional Outcome of Spinal Cord Injured Patients

Azienda Usl di Bologna8 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年8月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
8
主要终点
Creation of a model which analyze relationship among laboratory investigations and primary lesion, secondary damage and functional impairment

研究概览

简要总结

The project is aimed to develop predictive indices of spinal cord injury severity through the analysis of cerebrospinal fluid of patient collected during acute injury.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • presence of cervical and thoracic Spinal Cord Injury
  • need to be submitted to spine surgical stabilization with posterior approach

排除标准

  • prior to recruitment, in the acute phase, treatment with steroid therapy

研究组 & 干预措施

lumbar puncture

Other

That's not really an arm label because the only intervention on the patients is the lumbar puncture

干预措施: Lumbar puncture (Other)

结局指标

主要结局

Creation of a model which analyze relationship among laboratory investigations and primary lesion, secondary damage and functional impairment

时间窗: Three years

Correlation of the dosage of more than 20 tentative biomarkers with the biological effect of Cerebrospinal Fluid exposure on human cell lines, in order to directly test those effects. The Cerebrospinal Fluid will be encoded using technical procedures, divided into aliquots, quickly frozen and stored at 80°C. Biomarkers will be measured in the Cerebrospinal Fluid, related to: * inflammatory and vascular reaction, by a cytokine panel including 12 different cytokines/chemochines; * neurodegeneration and excitotoxicity, by a panel of 10 different biomarkers.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验